Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Spinraza regulatory update

April 26, 2017 6:57 PM UTC

EMA’s CHMP recommended approval of an MAA from Biogen for Spinraza nusinersen to treat spinal muscular atrophy (SMA). The product has Orphan Drug designation and is under accelerated assessment in the...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article